Tuesday, May 26, 2020

Biocon gets drug regulator#39;s nod for CytoSorb device to treat critical COVID-19 patients

Biocon gets drug regulator#39;s nod for CytoSorb device to treat critical COVID-19 patients "The goal of CytoSorb therapy is to reduce cytokine storm and the deadly inflammatory response through blood purification so that this injury may be mitigated or prevented," the company added.

from Moneycontrol Business News https://ift.tt/3gtAGyI

No comments:

Post a Comment

Apollo Micro Systems shares surge 15% following Rs 25 cr order wins from DRDO, other defence PSUs

Apollo Micro Systems shares saw a significant rise. The company secured orders worth Rs 25.12 crores from DRDO and Defence PSUs. This news b...